Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 124
1999 165
2000 159
2001 149
2002 142
2003 134
2004 170
2005 218
2006 223
2007 218
2008 198
2009 183
2010 302
2011 344
2012 320
2013 257
2014 211
2015 179
2016 169
2017 176
2018 185
2019 176
2020 142
2021 147
2022 143
2023 156
2024 152
2025 207
2026 85

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,689 results

Results by year

Filters applied: . Clear all
Page 1
European guidelines on diagnosis and treatment of phenylketonuria: First revision.
van Wegberg AMJ, MacDonald A, Ahring K, Bélanger-Quintana A, Beblo S, Blau N, Bosch AM, Burlina A, Campistol J, Coşkun T, Feillet F, Giżewska M, Huijbregts SC, Leuzzi V, Maillot F, Muntau AC, Rocha JC, Romani C, Trefz F, van Spronsen FJ. van Wegberg AMJ, et al. Mol Genet Metab. 2025 Jun;145(2):109125. doi: 10.1016/j.ymgme.2025.109125. Epub 2025 Apr 30. Mol Genet Metab. 2025. PMID: 40378670 Free article. Review.
Pompe disease: Unmet needs and emerging therapies.
George KA, Anding AL, van der Flier A, Tomassy GS, Berger KI, Zhang TY, Sardi SP. George KA, et al. Mol Genet Metab. 2024 Nov;143(3):108590. doi: 10.1016/j.ymgme.2024.108590. Epub 2024 Oct 11. Mol Genet Metab. 2024. PMID: 39418752 Review.
Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop.
Grünert SC, Derks TGJ, Mundy H, Dalton RN, Donadieu J, Hofbauer P, Jones N, Uçar SK, LaFreniere J, Contreras EL, Pendyal S, Rossi A, Schneider B, Spiegel R, Stepien KM, Wesol-Kucharska D, Veiga-da-Cunha M, Wortmann SB. Grünert SC, et al. Mol Genet Metab. 2024 Mar;141(3):108144. doi: 10.1016/j.ymgme.2024.108144. Epub 2024 Jan 17. Mol Genet Metab. 2024. PMID: 38277989 Free article. Review.
MGM and Undiagnosed Diseases.
Gahl WA. Gahl WA. Mol Genet Metab. 2024 Jan;141(1):108125. doi: 10.1016/j.ymgme.2024.108125. Epub 2024 Jan 4. Mol Genet Metab. 2024. PMID: 38184431 No abstract available.
Molecules, metabolism and genetics.
Morava E. Morava E. Mol Genet Metab. 2024 Jan;141(1):108126. doi: 10.1016/j.ymgme.2024.108126. Epub 2024 Jan 4. Mol Genet Metab. 2024. PMID: 38184430 No abstract available.
Challenges in Gaucher disease: Perspectives from an expert panel.
Grabowski GA, Kishnani PS, Alcalay RN, Prakalapakorn SG, Rosenbloom BE, Tuason DA, Weinreb NJ. Grabowski GA, et al. Mol Genet Metab. 2025 May;145(1):109074. doi: 10.1016/j.ymgme.2025.109074. Epub 2025 Mar 10. Mol Genet Metab. 2025. PMID: 40112481 Free article. Review.
Two Decades of WORLDSymposium™.
Whitley CB. Whitley CB. Mol Genet Metab. 2024 Feb;141(2):108107. doi: 10.1016/j.ymgme.2023.108107. Epub 2023 Dec 12. Mol Genet Metab. 2024. PMID: 38155037 No abstract available.
WORLDSymposium™ 2024 Introduction.
[No authors listed] [No authors listed] Mol Genet Metab. 2024 Feb;141(2):108094. doi: 10.1016/j.ymgme.2023.108094. Mol Genet Metab. 2024. PMID: 38307692 No abstract available.
4,689 results